Recent studies have shown that drugs that are normally unable to cross the blood-brain barrier (BBB) following intravenous injection can be transported across this barrier by binding to poly(butyl cyanoacrylate) nanoparticles and coating with polysorbate 80. However, the mechanism of this transport so far was not known. In the present paper, the possible involvement of…
Journal of drug targeting Template
Write in a clean editor, then format for Journal of drug targeting in one click — DocuGuru applies the official Taylor & Francis template with author–year references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
About the Journal of drug targeting format
Journal of drug targeting is a peer-reviewed journal published by Taylor & Francis, covering Nanoparticle-Based Drug Delivery, RNA Interference and Gene Delivery, Advanced Drug Delivery Systems.
| Publisher | Taylor & Francis |
|---|---|
| Reference style | Author–year (Chicago, T&F) Author–year — (Smith, 2023) in the text Smith, Ada, Ben Jones, and Cara Lee. 2023. "A Representative Article Title." Journal of drug targeting 12 (3): 45–58.
Formats any DOI in Journal of drug targeting style. No sign-up. |
| Publishes research in | Nanoparticle-Based Drug Delivery RNA Interference and Gene Delivery Advanced Drug Delivery Systems Advanced biosensing and bioanalysis techniques Advancements in Transdermal Drug Delivery |
| ISSN | 1026-7158 |
| Citation impact (2-yr) | 5.01 |
| h-index | 119 |
| i10-index | 1,909 |
| Total citations | 93,768 |
| Top institutions publishing here | Dr. Hari Singh Gour University |
| Journal website | informahealthcare.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Papers published in Journal of drug targeting per year
Citation impact of Journal of drug targeting by publication year
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Most-cited papers in Journal of drug targeting
PURPOSE: The blood-brain barrier (BBB) presents both a physical and electrostatic barrier to limit brain permeation of therapeutics. Previous work has demonstrated that nanoparticles (NPs) overcome the physical barrier, but there is little known regarding the effect of NP surface charge on BBB function. Therefore, this work evaluated: (1) effect of neutral, anionic and cationic…
Nanoparticles as drug delivery system have received much attention in recent years, especially for cancer treatment. In addition to improving the pharmacokinetics of the loaded poorly soluble hydrophobic drugs by solubilizing them in the hydrophobic compartments, nanoparticles allowed cancer specific drug delivery by inherent passive targeting phenomena and adopted active targeting strategies. For this reason,…
Over the past two decades cancer has ascended the causes of human death to be number one or two in many nations world wide. A major limitation inherent to most conventional anticancer chemotherapeutic agents is their lack of tumor selectivity. One way to achieve selective drug targeting to solid tumors is to exploit abnormalities of…
The influence of physicochemical properties, including lipophilicity, H-bonding capacity and molecular size and shape descriptors on brain uptake has been investigated using a selection of marketed CNS and CNS-inactive drugs. It is demonstrated that the polar surface area of a drug can be used as a suitable descriptor for the drugs' H-bonding potential. A combination…